Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tinatin, Antadze"'
Autor:
Manana, Giorgobiani, Margaret H, Burroughs, Tinatin, Antadze, Timothy J, Carrothers, Todd A, Riccobene, Rinal, Patel, Tao, Lin, Penka, Stefanova
Publikováno v:
Pediatric Infectious Disease Journal. 42:199-205
Acute bacterial skin and skin structure infections (ABSSSIs) are a significant source of morbidity in children. Dalbavancin, approved for the treatment of adults and children with ABSSSI, has a well-established safety profile in adults. We report saf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcf771d4ebf2879688572c58af65db55
https://doi.org/10.1097/inf.0000000000003798
https://doi.org/10.1097/inf.0000000000003798
Autor:
Carisa De Anda, Mohammed S Tayob, Jason Y Kim, Natasha Broyde, Tinatin Antadze, Borislav Ninov, Pamela Sears, Joan R. Butterton, Margaret Z Chou, John S. Bradley
Publikováno v:
Pediatric Infectious Disease Journal. 40:238-244
BACKGROUND Tedizolid phosphate is an oxazolidinone prodrug approved in 2014 for treatment of adults with acute bacterial skin and skin structure infections (ABSSSIs); however, efficacy has not previously been evaluated in children. This study compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d95fb626110543ce663e36eab62530b0
https://doi.org/10.1097/inf.0000000000003010
https://doi.org/10.1097/inf.0000000000003010
Autor:
Carisa De Anda, Joan R. Butterton, Margaret Z Chou, Ismail Mitha, Natasha Broyde, Pamela Sears, Mohammed S Tayob, Tinatin Antadze, Jason Y Kim, John S. Bradley, Borislav Ninov
Publikováno v:
Open Forum Infectious Diseases
Background Tedizolid phosphate has activity against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus, and was approved for the treatment of ABSSSI in adults in 2014. This study compared the safety and efficacy of TZD wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a59e11cef699a04b89507913d7d082
https://doi.org/10.1093/ofid/ofz360.544
https://doi.org/10.1093/ofid/ofz360.544
Autor:
Martin E. Stryjewski, Bartosz Korczowski, Tanya O'Neal, Alexander Smith, Manana Giorgobiani, Alena Jandourek, Tinatin Antadze, John S. Bradley
Publikováno v:
The Pediatric infectious disease journal. 35(8)
Ceftaroline has in vitro activity against bacterial isolates, including methicillin-resistant Staphylococcus aureus. This is the first study to investigate ceftaroline fosamil in pediatric patients with acute bacterial skin and skin structure infecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64e5ceab9d5549551930d6416f5a7b29
https://pubmed.ncbi.nlm.nih.gov/27164462
https://pubmed.ncbi.nlm.nih.gov/27164462